Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)
Status:
Completed
Trial end date:
2009-01-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of telcagepant
(MK-0974) in the long-term treatment of acute migraine in adult participants. The primary
hypothesis of this study is that telcagepant is well tolerated in the long-term treatment of
acute migraine in adult participants.